Company Overview of Aisling Capital LLC
Aisling Capital LLC is a venture capital and private equity firm specializing in investments in seed and venture financings of development-stage, mid venture, growth capital, industry consolidations, product acquisitions, positioning companies in the public stock markets, and follow-on financings. The firm focuses on small-cap publicly traded equities, structured debt and royalty deals and large-cap leveraged buyouts. The firm seeks to invest in life sciences, healthcare products, services, and technologies. It typically invests in private and public healthcare companies, life science, companies developing pharmaceutical, biotechnology, medical products, alternative energy resources, and bus...
888 Seventh Avenue
New York, NY 10106
Founded in 2000
Key Executives for Aisling Capital LLC
Founder and Senior Advisor
Chief Financial Officer and Chief Compliance Officer
Managing Partner and Managing Director
Compensation as of Fiscal Year 2015.
Aisling Capital LLC Key Developments
Aisling Capital Appoints Eric Aguiar as Partner
Jan 8 16
Aisling Capital has appointed Eric Aguiar, MD to the firm as a partner, bringing experience in drug development, commercialization and strategic leadership, to invest in biopharma opportunities across a range of therapeutic areas and stages of development. Prior to joining Aisling, Dr. Aguiar was a partner at Thomas, McNerney & Partners.
Aisling Capital LLC Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 12:00 PM
Dec 8 15
Aisling Capital LLC Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 12:00 PM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States. Speakers: Dennis J. Purcell, Founder and Senior Advisor.
Aisling Capital Names Scott Braunstein, MD as an Operating Partner
Aug 10 15
Aisling Capital announced that Scott Braunstein, MD has joined the firm as an operating partner. Dr. Braunstein will assist in evaluating potential future investments for the firm, as well as working broadly with Aisling portfolio companies. Dr. Braunstein serves as Senior Vice President, Strategy and Corporate Development at Pacira Pharmaceuticals. He spent 12 years as a Healthcare Analyst and Portfolio Manager at J.P. Morgan Asset Management, where he invested in and conducted diligence on a wide variety of pharmaceutical products and product candidates. Dr. Braunstein serves as a director of Esperion Therapeutics, STAT Medical and the Cornell Alumni Association for the College of Agriculture and Life Sciences.
Similar Private Companies By Industry
Recent Private Companies Transactions